MCM
REPL icon

Moore Capital Management’s Replimune Group REPL Stock Holding History

Moore Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Buy
+311,124
New +$2.38M 0.05% 260

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Moore Capital Management's REPL Position: Q1 2026 in Review

Moore Capital Management opened a new position in Replimune Group (REPL) in Q1 2026: 311,124 shares worth $2.38M. The stake represents 0.05% of the portfolio and ranks #260 among its holdings.

180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Moore Capital Management held 311,124 shares of Replimune Group worth $2.38M as of Q1 2026.
  • Replimune Group was a new Moore Capital Management position in Q1 2026.
  • Replimune Group made up 0.05% of Moore Capital Management's portfolio in Q1 2026, its #260 holding.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.